SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $26,000 | +8.3% | 100,000 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | -31.4% | 100,000 | 0.0% | 0.00% | – |
| Q4 2015 | $35,000 | -79.9% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $174,000 | -97.2% | 100,000 | -96.9% | 0.00% | -97.1% |
| Q1 2015 | $6,286,000 | +132.0% | 3,240,000 | +260.0% | 0.04% | +84.2% |
| Q3 2014 | $2,709,000 | +160.0% | 900,000 | +445.5% | 0.02% | +90.0% |
| Q3 2013 | $1,042,000 | – | 164,980 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|